ZULVIDA

Serial Number 98756788
688

Registration Progress

Application Filed
Sep 18, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 17, 2025 157 days

Trademark Image

ZULVIDA

Basic Information

Serial Number
98756788
Filing Date
September 18, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 17, 2025
Application
Pending
Classes
005 016 044

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

Next Deadline
157 days remaining
NOA E-Mailed - SOU Required
Due Date
December 17, 2025
Extension Available
Until June 17, 2026

Application History

9 events
Date Code Type Description
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2025 DOCK D ASSIGNED TO EXAMINER
Mar 25, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2024 MAFR O APPLICATION FILING RECEIPT MAILED
Sep 18, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders

Classification

International Classes
005 016 044

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO